NLRP3 and acute myeloid leukemia: Accordingly, inhibition of NLRP3 inflammasome activation impaired AML cell proliferation in vitro, whereas upregulation of NLRP3 promoted AML progression and mortality in vivo in mice, identifying NLRP3 as a potential driver of AML [10].